Genetic heterogeneity of Myc-induced mammary tumors reflecting diverse phenotypes including metastatic potential

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 38, 2009, Pages 16387-16392

  Andrechek, Eran R ^a   Cardiff, Robert D ^b   Chang, Jeffrey T ^a   Gatza, Michael L ^a   Acharya, Chaitanya R ^a   Potti, Anil ^a   Nevins, Joseph R ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast; Cancer; Genomics; Mouse

Indexed keywords

BETA CATENIN; MYC PROTEIN; RAS PROTEIN; STAT3 PROTEIN;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST TUMOR; CELL ACTIVATION; GENE MUTATION; GENETIC HETEROGENEITY; HISTOPATHOLOGY; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ACTINS; ANIMALS; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC HETEROGENEITY; IMMUNOHISTOCHEMISTRY; KERATIN-18; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; MUSCLE, SMOOTH; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS V-MYB; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIMENTIN;

MOUSE MAMMARY TUMOR VIRUS;

EID: 70349496099     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0901250106     Document Type: Article

References (27)

1. Weir BA, et al. (2007) Characterizing the cancer genome in lung adenocarcinoma. Nature 450:893-898.
2. Wood LD, et al. (2007) The genomic landscapes of human breast and colorectal cancers. Science 318:1108-1113. (Pubitemid 350134889)
3. Sjoblom T, et al. (2006) The consensus coding sequences ofhumanbreast and colorectal cancers. Science 314:268-274. (Pubitemid 44571966)
4. Mullighan CG, et al. (2007) Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446:758-764.
5. Ding L, et al. (2008) Somatic mutations effect key pathways in lung adenocarcinoma. Nature 455:1069-1075.
6. Cardiff RD, et al. (2000) The mammary pathology of genetically engineered mice: The consensus report and recommendations from the Annapolis meeting. Oncogene 19:968-988.
7. Sears RC, Nevins JR (2002) Signaling networks that link cell proliferation and cell fate. J Biol Chem 277:11617-11620.
8. Sears R, et al. (2000) Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev 14:2501-2514. (Pubitemid 30761517)
9. Sears R, Leone G, DeGregori J, Nevins JR (1999) Ras enhances Myc protein stability. Mol Cell 3:169-179. (Pubitemid 29292618)
10. Sinn E, et al. (1987) Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell 49:465-475. (Pubitemid 18091823)
11. D'Crus CM, et al. (2001) c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat Med 7:235-239.
12. Li Y, et al. (2003) Evidence that transgenes encoding components of hte Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci 100:15853-15858. (Pubitemid 38021079)
13. Damonte P, Gregg JP, Borowsky AD, Keister BA, Cardiff RD (2007) EMT tumorigenesis in the mouse mammary gland. Lab Invest 87:1218-1226. (Pubitemid 350126707)
14. Herschkowitz JI, et al. (2007) Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 8:R76.
15. Amundadottir KT, Johnson MD, Merlino G, Smith GH, Dickson RB (1995) Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis. Cell Growth Differ 6:737-748.
16. Hundley JE, et al. (1997) Differential regulation of cell cycle characteristics and apoptosis in MMTV-myc and MMTV-ras mouse mammary tumors. Cancer Res 57:600-603.
17. Calvo A, et al. (2008) Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis. Oncogene 27:5373-5384.
18. Acharya CR, et al. (2008) Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer. JAMA 299:1574-1587.
19. Minn AJ, et al. (2005) Genes that mediate breast cancer metastasis to lung. Nature 436:518-524.
20. Ansieau S, et al. (2008) Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 14:79-89. (Pubitemid 351890463)
21. Morel AP, et al. (2008) Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLOS ONE 3:e2888.
22. Podsypanina K, Politi K, Beverly LJ, Varmus HE (2008) Oncogene cooperation in tumor maintenance and tumor recurrence in mouse mammary tumors induced by Myc and mutant Kras. Proc Natl Acad Sci USA 105:5242-5247. (Pubitemid 351738541)
23. Jang JW, Boxer RB, Chodosh LA (2006) Isoform-specific ras activation and oncogene dependence during MYC- and Wnt-induced mammary tumorigenesis. Mol Cell Biol 26:8109-8121.
24. Guy CT, Cardiff RD, Muller WJ (1992) Induction of mammary tumors by expression of polyomarirus middle T oncogene: A transgenic mouse model for metastatic disease. Mol Cell Biol 12:954-961.
25. Siegel PM, Dankort DL, Hardy WR, Muller WJ (1994) Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. Mol Cell Biol 14:7068-7077.
26. Rauh MJ, et al. (1999) Accelerated mammary tumor development in mutant polyomavirus middle T transgenic mice expressing elevated levels of either the Shc or Grb2 adapter protein. Mol Cell Biol 19:8169-8179.
27. Andrechek ER, Mori S, Rempel RE, Chang JT, Nevins JR (2008) Patterns of cell signaling pathway activation that characterize mammary development. Development 135:2403-2411.